CORRECTING and REPLACING Bristol Myers Squibb Announces Opdivo (nivolumab) plus Chemotherapy and Opdivo plus Yervoy (...
PRINCETON, N.J.--(BUSINESS WIRE)--Apr 8, 2021-- Please replace the release with the following corrected version due to revisions to paragraph under INDICATIONS. The updated release reads: Bristol Myers Squibb Announces Opdivo (nivolumab) plus Chemotherapy …